Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy
نویسندگان
چکیده
منابع مشابه
gene expression profiling for cancer targeted therapy
background : lung cancer is still the leading cause of cancer- related deaths and most of themâ are normally diagnosed in late stages, so there is an urgent need to establish reliable tools for the identification at early stages of the disease. in this study, we use an eleven gene signature test to examine lung biopsy specimens for diagnostic, prognostic & therapeutic purposes. methods : bronc...
متن کاملUnexpected insights for anti-EGFR cancer therapy
Colorectal cancer (CRC) is a major cause of morbidity and mortality. It accounts for over 9% of all malignancies, making it the third most common cancer worldwide and second most common cause of death in the developed world. Treatment of metastatic colorectal cancer (mCRC) is largely palliative, making potentially curative therapy via molecular inhibition of specific cellular targets in CRC a h...
متن کاملOptimizing the sequence of anti-EGFR-targeted therapy in EGFR-mutant lung cancer.
Metastatic EGFR-mutant lung cancers are sensitive to the first- and second-generation EGFR tyrosine kinase inhibitors (TKIs) gefitinib, erlotinib, and afatinib, but resistance develops. Acquired resistance to gefitinib or erlotinib occurs most commonly (>50%) via the emergence of a second-site EGFR mutation, T790M. Two strategies to overcome T790M-mediated resistance are dual inhibition of EGFR...
متن کاملRadiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy †
The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody cetuximab has been approved alone or in combination with: (a) chemotherapy for treatment of colorectal and head and neck squamous cell carcinoma and (b) with external radiotherapy for treatment of head and neck squ...
متن کاملAnti Cancer Drugs Used for Targeted Therapy
A primary goal of targeted therapy is to fight cancer cells with more precision and potentially fewer side effects. For this reason it is a promising therapy for the 3rd millennium1. Traditional cytotoxic chemotherapy works primarily through the inhibition of cell division. In addition to cancer cells, other rapidly dividing cells (e.g. hair, gastrointestinal epithelium, bone marrow) are affect...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Oncology
سال: 2016
ISSN: 1019-6439,1791-2423
DOI: 10.3892/ijo.2016.3619